Group metacognitive therapy for repetitive negative thinking in primary and non-primary generalized anxiety disorder: An effectiveness trial
Open accessAbstract
Background Generalized anxiety disorder (GAD) is a common and highly comorbid anxiety disorder characterized by repetitive negative thinking (RNT). Treatment trials tend to exclude individuals with non-primary GAD, despite this being a common presentation in real world clinics. RNT is also associated with multiple emotional disorders, suggesting that it should be targeted regardless of the primary disorder. This study evaluated the acceptability and effectiveness of brief group metacognitive therapy (MCT) for primary or non-primary GAD within a community clinic. Methods Patients referred to a specialist community clinic attended six, two-hour weekly sessions plus a one-month follow-up (N=52). Measures of metacognitive beliefs, RNT, symptoms, positive and negative affect, and quality of life were completed at the first, last, and follow-up sessions. Results Attrition was low and large intent-to-treat effects were observed on most outcomes, particularly for negative metacognitive beliefs and RNT. Treatment gains increased further to follow-up. Benchmarking comparisons demonstrated that outcomes compared favorably to longer disorder-specific protocols for primary GAD. Limitations No control group or independent assessment of protocol adherence. Conclusions Brief metacognitive therapy is an acceptable and powerful treatment for patients with primary or non-primary GAD. © 2014 Elsevier B.V.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
5 of 63 cited sources checked · 3 supported · 0 flagged · accuracy not yet measured
- Study design and conductcitation
The present study satisfied multiple effectiveness-trial criteria involving representative patients, therapists, and services.
“This study met several criteria for an effectiveness trial, including clinically representative patients (various primary disorders, highly comorbid, severe, referred by health practitioners), therapists (broad caseload, various levels of experience), and services (naturalistic community mental health clinic, Stewart & Chambless, 2009).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Stewart & Chambless, 2009 source
- Premisecitation
Meta-analytic evidence on routine-care outcomes supports the idea that treatments shown to work in trials can also work well in non-research settings.
“Meta-analyses investigating the effectiveness of treatments under real world conditions have supported the proposition that efficacious protocols can be highly effective outside of research trials (Stewart & Chambless, 2009).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Stewart & Chambless, 2009 source
- Premisecitation
Newman et al.'s (2011) integrated 14-session cognitive behavioral and interpersonal plus emotional processing therapy produced effect sizes comparable to this study.
“Newman et al.'s (2011) evaluation of an integrated, 14-session CBT and interpersonal plus emotional processing therapy also resulted in comparable effect sizes to our study.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Newman et al.'s (2011) source
- Findingown data
Including a subsample with non-primary generalized anxiety disorder did not adversely affect change in the primary therapeutic targets.
“The findings of this study suggest that including a subsample with non-primary GAD did not adversely affect change in the primary therapeutic targets, which is important because many community clinics may not receive enough referrals to run groups based on primary disorders.”
Quote in the paperSubstantial claim- Rests on an assumption: Many community clinics may not receive enough referrals to run groups based on primary disorders.
- Findingown data
Group metacognitive therapy was associated with significant and substantial improvements in symptoms.
“Group MCT had low attrition and was associated with significant and substantial improvements in RNT, metacognitions, higher-order dimensions of positive and negative affect, symptoms, and quality of life.”
Quote in the paperSubstantial claim
- Findingown data
Reductions in negative metacognitive beliefs about uncontrollability and dangerousness were considerably larger than reductions in positive metacognitions.
“MCT was associated with significant reductions in both positive and negative metacognitive beliefs, although the reductions were considerably larger for negative (uncontrollability and dangerousness) than positive metacognitions.”
Quote in the paperNot a substantial claim - Findingown data
Group metacognitive therapy had low attrition.
“Group MCT had low attrition and was associated with significant and substantial improvements in RNT, metacognitions, higher-order dimensions of positive and negative affect, symptoms, and quality of life.”
Quote in the paperSubstantial claim - Findingown data
The post-treatment PSWQ standard deviation in this study (6.9) was less than half the standard deviation reported by van der Heiden et al. (2012; 15.8).
“the post-treatment PSWQ standard deviation in this study (SD = 6.9) was less than half that reported by van der Heiden et al. (2012, SD = 15.8)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van der Heiden et al. (2012) source
- Rests on an assumption: Effect sizes from different studies can be validly compared using benchmarking.
- Findingown data
Group metacognitive therapy was associated with significant and substantial improvements in higher-order dimensions of positive and negative affect.
“Group MCT had low attrition and was associated with significant and substantial improvements in RNT, metacognitions, higher-order dimensions of positive and negative affect, symptoms, and quality of life.”
Quote in the paperSubstantial claim - Findingown data
This study's effect sizes were slightly smaller than those of van der Heiden et al.'s (2012) individual treatment.
“The effect sizes from this study were slightly smaller than van der Heiden et al.'s (2012) individual treatment.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van der Heiden et al. (2012) source
- Rests on an assumption: Effect sizes from different studies can be validly compared using benchmarking.
- Findingreasoning
In this study, including unpaid trainee co-therapists in the group treatment resulted in 2.96 therapy hours and 3.96 therapist hours per patient.
“Including these trainees as cotherapists translates to 2.96 therapy hours/patient and 3.96 therapist hours/patient.”
Quote in the paperNot a substantial claim - Findingown data
Other measures showed medium to very large effects.
“There were also medium to very large effects observed on the other measures.”
Quote in the paperSubstantial claim - Findingown data
Metacognitive therapy was associated with significant reductions in both positive and negative metacognitive beliefs.
“MCT was associated with significant reductions in both positive and negative metacognitive beliefs, although the reductions were considerably larger for negative (uncontrollability and dangerousness) than positive metacognitions.”
Quote in the paperSubstantial claim - Findingown data
Treatment gains generally increased between post-treatment and follow-up.
“Effect sizes for most measures increased between post-treatment and follow up.”
- Also stated in: § Abstract · plain
“Treatment gains increased further to follow-up.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
These proportions were favorable compared with van der Heiden et al. (2012, 2013) individual and group metacognitive therapy outcomes using the same criterion (60-77% reliably improved, 37-63% recovered).
“These proportions compared well to van der Heiden et al.'s (2012) and van der Heiden et al.'s (2013) individual and group MCT outcomes, who used the same criterion (60-77% reliably improved, 37%-63% recovered).”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
All 14 measures showed statistically significant improvement from pre- to post-treatment (all p < .001).
“There were statistically significant improvements on all 14 measures between pre-and post-treatment (all ps < .001).”
Quote in the paperSubstantial claim - Findingown data
Group metacognitive therapy was associated with significant and substantial improvements in quality of life.
“Group MCT had low attrition and was associated with significant and substantial improvements in RNT, metacognitions, higher-order dimensions of positive and negative affect, symptoms, and quality of life.”
Quote in the paperSubstantial claim - Findingreasoning
Benchmarking comparisons indicated that this study's brief 6-week MCT group program produced substantially larger changes in worry than van der Heiden et al.'s (2013) group treatment, despite similar therapist hours per patient.
“Benchmarking comparisons found that the brief, 6-week MCT group program evaluated in this study was associated with substantially larger changes in worry than van der Heiden et al.'s (2013) group treatment, which required a similar number of therapist hours per patient.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van der Heiden et al. (2013) source
- Rests on an assumption: Effect sizes from different studies can be validly compared using benchmarking.
- Findingown data
The current study's effect sizes were numerically larger than those in most of the benchmark randomized trials.
“Effect sizes in the current study were numerically larger than those observed in most of the RCTs.”
Quote in the paperSubstantial claim - Findingown data
At pre-treatment, no patient scored below the clinical cutoff.
“No patients fell below this clinical cutoff at pre-treatment.”
Quote in the paperNot a substantial claim - Findingown data
From pre-treatment to follow-up, repetitive thinking decreased by 15.53 points (95% CI 13.40 to 17.66; d=2.22).
“Follow Up | 24.83 8.26 | 15.53 13.40 17.66 | 2.22 1.63 2.81”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, repetitive thinking decreased by 12.26 points (95% CI 9.93 to 14.59; d=1.75).
“Post | 28.10 8.31 | 12.26 | 9.93 14.59 | 1.75 1.20 2.30”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to follow-up, worry decreased by 17.64 points (95% CI 15.16 to 20.13; d=2.19).
“Follow Up | 48.50 9.25 | 17.64 15.16 20.13 | 2.19 1.66 2.71”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to follow-up, positive metacognitions decreased by 3.74 points (95% CI 2.51 to 4.97; d=0.81).
“Follow Up | 8.39 | 3.11 | 3.74 | 2.51 | 4.97 | .81 | .53 1.08”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, depressive cognitions decreased by 7.69 points (95% CI 5.39 to 9.99; d=0.80).
“Post | 15.78 10.31 | 7.69 | 5.39 | 9.99 | .80 | .48 1.11”
Quote in the paperNot a substantial claim - Findingown data
From pre-treatment to follow-up, reflective rumination decreased by 1.62 points (95% CI 0.63 to 2.61; d=0.42).
“Follow Up | 9.63 | 3.12 | 1.62 | 0.63 | 2.61 | .42 | .16 0.68”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, reflective rumination decreased by 1.90 points (95% CI 0.98 to 2.83; d=0.49).
“Post | 9.34 | 2.59 | 1.90 | 0.98 | 2.83 | .49 | .25 0.74”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, negative metacognitions decreased by 6.94 points (95% CI 5.80 to 8.07; d=1.90).
“Post | 10.99 3.94 | 6.94 | 5.80 | 8.07 | 1.90 1.35 2.45”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, brooding rumination decreased by 2.79 points (95% CI 1.98 to 3.60; d=0.82).
“Post | 10.27 2.92 | 2.79 | 1.98 | 3.60 | .82 | .53 1.11”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to follow-up, negative metacognitions decreased by 8.30 points (95% CI 7.05 to 9.54; d=2.27).
“Follow Up | 9.63 | 4.23 | 8.30 | 7.05 | 9.54 | 2.27 1.68 2.86”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, worry decreased by 14.65 points (95% CI 12.28 to 17.02; d=1.82).
“Post | 51.49 9.00 | 14.65 12.28 17.02 | 1.82 1.34 2.29”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, positive metacognitions decreased by 2.50 points (95% CI 1.19 to 3.81; d=0.54).
“Post | 9.63 | 3.83 | 2.50 | 1.19 | 3.81 | .54 | .26 | .82”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to post-treatment, anxious cognitions decreased by 4.74 points (95% CI 2.99 to 6.50; d=0.53).
“Post | 10.76 8.58 | 4.74 | 2.99 | 6.50 | .53 | .30 | .76”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to follow-up, anxious cognitions decreased by 6.59 points (95% CI 4.72 to 8.45; d=0.74).
“Follow Up | 8.91 | 7.64 | 6.59 | 4.72 | 8.45 | .74 | .50 | .97”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to follow-up, brooding rumination decreased by 3.61 points (95% CI 2.73 to 4.49; d=1.06).
“Follow Up | 9.44 | 2.32 | 3.61 | 2.73 | 4.49 | 1.06 | .79 1.34”
Quote in the paperSubstantial claim - Findingown data
From pre-treatment to follow-up, depressive cognitions decreased by 11.84 points (95% CI 9.59 to 14.08; d=1.22).
“Follow Up | 11.64 9.00 | 11.84 | 9.59 14.08 | 1.22 | .89 1.56”
Quote in the paperSubstantial claim - Interpretationreasoning
Treatments aimed at repetitive negative thinking may work whether or not GAD is the primary disorder.
“Interventions targeting RNT may therefore be effective regardless of whether GAD is primary or not.”
Quote in the paperSubstantial claim - Premisecitation
In a randomized trial with 126 primary GAD patients, van der Heiden et al. (2012) found 14 individual metacognitive therapy sessions outperformed intolerance-of-uncertainty therapy and a delayed-treatment control.
“van der Heiden, Muris, and van der Molen (2012) conducted a randomized controlled trial (RCT, N = 126) for primary GAD and found that 14 sessions of individual MCT was superior to intolerance of uncertainty therapy (IUT) and a delayed treatment control (DT).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van der Heiden, Muris, and van der Molen (2012) source
- Premisecitation
The sole other trial of group metacognitive therapy enrolled eight adults with obsessive-compulsive disorder.
“The only other group MCT trial included just eight adults with obsessive compulsive disorder (Rees & van Koesveld, 2008), suggesting that more research is required to more fully evaluate the utility of group MCT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rees & van Koesveld, 2008 source
- Premisecitation
The S-REF model underlying metacognitive therapy is described as transdiagnostic.
“The S-REF model, from which MCT derives, is a transdiagnostic theory (Wells & Matthews, 1996).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wells & Matthews, 1996 source
- Interpretationreasoning
Metacognitive therapy ought to reduce repetitive negative thinking irrespective of the particular negative thought content or the patient's primary diagnosis.
“MCT should therefore effectively reduce RNT regardless of the specific content of negative thoughts or primary diagnosis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wells & Matthews, 1996 source
- Premisecitation
Theory and growing evidence suggest repetitive negative thinking plays a causal role in maintaining several emotional disorders.
“Indeed, theory and accumulating evidence causally implicate RNT in the maintenance of various emotional disorders (Harvey, Watkins, Mansell, & Shafran, 2004;McEvoy & Brans, 2013;Nolen-Hoeksema & Watkins, 2011)”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Most studies of evidence-based treatments limit their samples to people who have one designated primary disorder.
“most trials of evidencebased treatments restrict clinical samples to individuals with a specific primary disorder.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brown, Campbell, Lehman, Grisham, & Mancill, 2001 source
- Premisecitation
Four trials of metacognitive therapy for primary GAD have reported substantial decreases in metacognitive beliefs and repetitive negative thinking.
“Four MCT treatment trials for primary GAD have demonstrated large reductions in metacognitive beliefs and RNT.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
In routine clinical practice, co-occurring disorders are typical rather than unusual.
“Despite comorbidity being the norm rather than the exception in clinical practice (Brown, Campbell, Lehman, Grisham, & Mancill, 2001)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brown, Campbell, Lehman, Grisham, & Mancill, 2001 source
- Interpretationown data
Benchmarking indicated that outcomes for primary GAD were at least as good as those from longer disorder-specific protocols.
“Benchmarking comparisons demonstrated that outcomes compared favorably to longer disorder-specific protocols for primary GAD.”
Quote in the paperSubstantial claim - Study design and conductown data
Internal consistency was high for all repetitive negative thinking measures in this sample (alpha .73 to .95).
“In this study Cronbach's alphas were high for all RNT measures (αs=.73-.95).”
Quote in the paperNot a substantial claim - Premisecitation
A cutoff of 59 was chosen because community and clinical norms indicate that 58 or 59 best separates normal from pathological worry.
“We used a cutoff of 59 as recently published community and clinical norms indicate that a score of 58 or 59 is the boundary that best differentiates normal and pathological worry (van der Heiden, Muris, Bos, Molen, & Oostra, 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van der Heiden, Muris, Bos, Molen, & Oostra, 2009 source
- Interpretationcitation
The relatively brief metacognitive therapy protocol produced changes comparable to substantially longer group and individual treatments.
“The relatively brief MCT protocol evaluated in this study resulted in comparable changes to substantially longer group and individual treatments.”
Quote in the paperSubstantial claim - Premisecitation
Van der Heiden et al. found that 14 sessions of MCT effectively reduced worry in patients with primary GAD.
“These authors found that 14 sessions of MCT effectively reduced worry for patients with primary GAD.”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Targeting transdiagnostic metacognitions rather than the content of diagnosis-specific cognitions makes the approach suitable for including diagnostically diverse samples.
“Targeting transdiagnostic metacognitions, rather than the content of diagnosis-specific cognitions, means that this approach is amenable to including diagnostically diverse samples.”
Quote in the paperSubstantial claim - Premisecitation
Van der Heiden et al. (2013) reported smaller effect sizes for group treatment than van der Heiden et al. (2012) reported for individual treatment.
“van der Heiden et al. (2013) found smaller effect sizes for their group treatment than for the same treatment offered individually by van der Heiden et al. (2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Study design and conductreasoning
The absence of a control group means that factors other than metacognitive therapy could not be ruled out as contributors to outcomes.
“Firstly, the absence of a control group means that we could not rule out the possibility that factors other than MCT contributed to outcomes (e.g., non-specifics of therapy, medication, time).”
Quote in the paperSubstantial claim - Study design and conductreasoning
Factors other than metacognitive therapy are unlikely to fully account for the outcomes because of the long median duration of medication use, the chronicity of self-reported repetitive negative thinking, and benchmarking comparisons showing comparable or superior outcomes to active treatments in randomized controlled trials and superior outcomes to waitlist controls.
“However, these factors are unlikely to fully account for the outcomes due to the long duration of medication use (median = 2 years), the chronicity of self-reported RNT, and the benchmarking comparisons demonstrating comparable or superior outcomes to active treatments in RCTs and superior outcomes to waitlist controls.”
Quote in the paperSubstantial claim - Interpretationreasoning
Once individuals can disengage from the process of repetitive negative thinking, the content of specific negative thoughts appears to intrude less frequently.
“Once individuals are equipped to disengage from the process of RNT then the content of specific negative thoughts appears to naturally intrude less frequently.”
Quote in the paperSubstantial claim - Interpretationown data
The smaller post-treatment PSWQ standard deviation suggests that group MCT produced a more consistent treatment effect.
“suggesting a more consistent treatment effect in group MCT.”
Quote in the paperNot a substantial claim- Rests on an assumption: Effect sizes from different studies can be validly compared using benchmarking.
- Classified as probably not a substantial claim. 30
- May combine two claims. 43
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S2 (checkable).
PremisecitationMore effectiveness studies in routine settings may be required before clinicians regard efficacy trials as helpful for their practice.
“However, recent evidence suggests that more real world effectiveness trials are needed before clinicians are likely to perceive efficacy trials as being useful for guiding their clinical interventions (Gyani, Shafran, Myles, & Rose, 2014).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Gyani, Shafran, Myles, & Rose, 2014 source
The Results section (headed “INSERT TABLE 2 ABOUT HERE”; no page number available) reports that therapists used controlled studies less often than several other sources of clinical guidance. The Discussion says therapists’ objections concern how research translates into practice. Neither passage says that more real-world effectiveness trials are needed before clinicians will find efficacy trials useful. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationFour subsequent trials of Intolerance of Uncertainty Therapy failed to replicate the magnitude of Ladouceur et al.'s effects; those trials still found the therapy effective, but their effect sizes were smaller than for the brief group metacognitive therapy evaluated in this study.
“Importantly, four subsequent trials of IUT failed to replicate the magnitude of Ladouceur et al.'s (2000) effects and, although they still found IUT to be effective, the effect sizes were smaller than for the brief group MCT protocol evaluated in this study (Dugas et al., 2003;Dugas et al., 2010;Gosselin, 2006;van der Heiden et al., 2012).”
Quote in the paperSubstantial claim1 of 3 sources checkedMay combine two claims.
Findingown dataRoughly two-thirds (35 patients, 67%) had taken psychiatric medication long term, median one year (interquartile range six months to four years), without adequate response.
“About two-thirds of patients were taking psychiatric medication (N = 35, 67%) for an extended period of time (median 1 year; interquartile range 6 months to 4 years) without responding adequately.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataFor most participants, the current episode had lasted more than a year (39 patients, 75%), with a median of three years.
“The duration of the current mental disorder episode exceeded a year for most of the sample (n = 39, 75%), with a median duration of three years.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA notable minority had self-harmed, attempted suicide, or been admitted to a psychiatric hospital.
“A significant minority of the sample had self-harmed, attempted suicide, or spent time as an inpatient at a psychiatric hospital.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEffect sizes were extremely large for negative metacognitions, worry, and repetitive negative thinking.
“Effect sizes were extremely large on the measures of negative metacognitions, worry, and RNT.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMost patients (46, 88%) attended at least five treatment sessions, and all but one attended at least four.
“Most patients attended at least five treatment sessions (N = 46, 88%), and all except one attended at least four.”
- Also stated in: § Abstract · plain
“Attrition was low”
Quote in the paperSubstantial claim- Also stated in: § Abstract · plain
May combine two claims.
Findingown dataEngagement in repetitive negative thinking significantly and substantially reduced during treatment, with very large effect sizes on the RTQ and PSWQ and large effect sizes on the RRS-Brooding subscale.
“Engagement in RNT significantly and substantially reduced during treatment, with very large effect sizes on the RTQ and PSWQ, and large effect sizes on the RRS-Brooding subscale.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDuring the 12-14 week waitlist period, mean PSWQ scores rose by .025 points (d = .03), suggesting stability without treatment.
“Mean PSWQ total scores increased by .025points (d = .03)during the waitlist period (12-14 weeks), suggesting that scores were stable without treatment.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt post-treatment, no patient had reliably deteriorated, 86% had reliably improved, and 74% had recovered.
“At post-treatment no patients had reliably deteriorated, 86% had reliably improved, CI [77%, 96%], p < .001,and 74% had recovered, CI [62%, 86%], p <.001.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt follow-up, effect sizes for negative metacognitions, worry, and repetitive negative thinking were very large and exceeded two standard deviations.
“The effect sizes for negative metacognitions, worry and RNT were very large at follow up, exceeding two standard deviations.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt pre-treatment, patients endorsed fewer positive metacognitive beliefs than negative metacognitive beliefs, producing a floor effect.
“It is notable that at pre-treatment patients endorsed fewer positive metacognitive beliefs, resulting in a floor effect, compared to negative metacognitive beliefs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe one-month follow-up was attended by 37 patients (71%).
“The one month follow-up was attended by 37 patients (71%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataUsing a lower PSWQ cutoff of 53, 85% and 90% showed reliable improvement at post-treatment and follow-up, respectively, and 65% recovered at both points.
“When a lower PSWQ cutoff of 53 was used, which has been applied in some recent studies, 85% and 90% achieved reliable improvement at post-treatment and follow-up, respectively, and 65% recovered at both post-treatment and follow-up.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataThe same reliable improvement and recovery percentages were found at follow-up.
“The percentages were the same at follow up.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe RTQ was equally sensitive to change as the PSWQ and more sensitive to change than the RRS subscales.
“Our findings suggest that it was equally sensitive to change as the PSWQ and more so than the RRS subscales.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningThe frequency of specific depressive and anxious negative thoughts reduced during treatment even though negative automatic thoughts were not directly addressed in the protocol.
“Interestingly, the frequency of specific depressive and anxious negative thoughts also reduced during treatment despite the fact that negative automatic thoughts were not directly addressed during the protocol.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe S-REF model proposes that favorable beliefs about repetitive negative thinking encourage people to engage in it more.
“Wells and Matthews' (1996) Self-Regulatory Executive Function (S-REF) model is a metacognitive account of emotional disorders, which suggests that positive beliefs about RNT (e.g., RNT is helpful) motivate an individual to engage more fully in RNT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wells and Matthews' (1996) source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAn experienced clinical psychologist in emotional disorder assessment and treatment administered the MINI.
“at which the MINI was completed by a Clinical Psychologist experienced in both the assessment and treatment of emotional disorders.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningLarge groups may have weakened treatment effects and increased dropout in van der Heiden et al. (2013).
“However, the large group sizes may have diluted treatment effects and contributed to the high attrition.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van der Heiden et al.'s (2013) source
May combine two claims.
Premisecitationvan der Heiden et al. (2013) tested 14 group metacognitive therapy sessions in 33 primary GAD patients and observed greater dropout (27% versus 11%) and weaker outcomes than individual metacognitive therapy.
“van der Heiden, Melchior, and de Stigter (2013) subsequently evaluated 14 sessions of group MCT for primary GAD (N = 33), but found higher dropout (27% vs. 11%) and poorer outcomes than van der Heiden et al.'s (2012) trial of individual MCT.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van der Heiden, Melchior, and de Stigter (2013) source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGeneralized anxiety disorder ranks among the most prevalent anxiety conditions and frequently co-occurs with other disorders.
“Generalized anxiety disorder (GAD) is one of the most common and highly comorbid anxiety disorders (Kessler, Chiu, Demler, & Walters, 2005;McEvoy, Grove, & Slade, 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThe groups in van der Heiden et al. (2013) were fairly large, with 10 to 14 patients each, which was more efficient than individual treatment.
“It is notable that van der Heiden et al.'s (2013) groups were relatively large (10-14 patients/group), which represents a considerable efficiency over individual treatment.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van der Heiden et al.'s (2013) source
Classified as probably not a substantial claim.
PremisecitationMetacognitive therapy addresses both favorable and unfavorable metacognitive beliefs that sustain the Cognitive Affective Syndrome.
“Whereas more traditional cognitive behavior therapy targets the content of negative automatic thoughts, MCT targets positive and negative metacognitive beliefs that maintain the CAS.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationThe van der Heiden et al. (2013) authors concluded that group metacognitive therapy may be less effective and acceptable than individual therapy, perhaps because less time was available to address each patient's unique metacognitive beliefs.
“The authors concluded that group MCT might be less effective and acceptable than individual MCT, possibly due to there being less time to challenge each individual's idiosyncratic metacognitive beliefs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van der Heiden, Melchior, and de Stigter (2013) source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationThe S-REF model proposes that as repetitive negative thinking increases, it reinforces beliefs that such thinking is uncontrollable and dangerous, leading people to give up helpful reduction efforts and use extreme overcontrol.
“This escalation of RNT strengthens negative beliefs about the uncontrollability and dangerousness of thoughts and, continuing the cycle, leads individuals to abandon functional attempts to reduce their engagement in RNT and instead to use more extreme and dysfunctional overcontrol strategies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wells and Matthews' (1996) source
Classified as probably not a substantial claim.
Study design and conductcitationDiagnoses of anxiety and/or depressive disorders were established with a structured interview, the Mini International Diagnostic Interview.
“A structured diagnostic interview (Mini International Diagnostic Interview, Lecrubier et al., 1997;Sheehan et al., 1998) was used to establish the presence of anxiety and/or depressive disorders.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Lecrubier et al., 1997 source
- cites Sheehan et al., 1998
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMajor depressive disorder co-occurs with GAD at especially high rates, with some estimates reaching 67%.
“Comorbidity with major depressive disorder is particularly high, with estimates up to 67% (Judd et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Judd et al., 1998 source
May combine two claims.
PremisecitationEvidence indicates metacognitive therapy helps with several primary emotional disorders besides GAD, including depression, social anxiety disorder, and obsessive-compulsive disorder.
“there is evidence that MCT is effective for a range of primary emotional disorders in addition to GAD, such as depression (Dammen, Papageorgiou, and Wells, in press;Papageorgiou & Wells, in press;Wells et al., 2012), social anxiety disorder (McEvoy, Mahoney, Perini, & Kingsep, 2009), and obsessive compulsive disorder (Rees & van Koesveld, 2008).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Dammen, Papageorgiou, and Wells, in press
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Papageorgiou & Wells, in press
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Wells et al., 2012 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataEvery case was discussed at weekly clinic meetings for diagnostic and treatment planning.
“In addition, all cases were presented at weekly clinic meetings where diagnoses and treatment plans were discussed.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationOne possible barrier to spreading evidence-based treatments is the belief that trial samples do not represent real-world patients.
“One potential obstacle to the dissemination of evidence-based treatments is the perception that real world samples are not reflected within treatment trials (Barlow, Levitt, & Bufka, 1999).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Barlow, Levitt, & Bufka, 1999 source
May combine two claims.
PremisecitationTwo early metacognitive therapy studies had encouraging results but only ten participants each, leaving their generalizability uncertain.
“Two preliminary studies demonstrated promising effects, but small samples (Ns = 10) raise questions about the generalizability of the findings (Wells et al., 2010;Wells & King, 2006).”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
PremisecitationWells (2013) contends that negative beliefs about repetitive negative thinking exert unusually broad and strong effects in psychological disorder, producing acute danger, hopelessness, and inefficacy.
“Wells (2013) argues that negative beliefs about RNT have the “...most pervasive and powerful influences in psychological disorder...giving rise to a sense of acute danger, hopelessness, and inefficacy (p.188-189).””
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wells (2013) source
Classified as probably not a substantial claim.
PremisecitationThe S-REF model holds that unfavorable beliefs about repetitive negative thinking produce unhelpful cognitive and behavioral responses.
“Once RNT is commenced, negative beliefs about RNT (e.g., RNT is dangerous and uncontrollable) then lead to a range of counterproductive cognitive (e.g., suppression, threat monitoring) and behavioral (e.g., avoidance, alcohol use) changes”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wells and Matthews' (1996) source
May combine two claims.
PremisecitationMost MCT studies have used very small samples, with exceptions being van der Heiden et al. (2012, N=61) and van der Heiden et al. (2013, N=33), which examined individual and group MCT respectively.
“Although most studies of MCT have used very small samples, two exceptions are van der Heiden et al. (2012, N = 61) and van der Heiden et al. (2013, N = 33), who evaluated individual and group MCT, respectively.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataThe frequency of negative thoughts reduced as a side effect of targeting metacognitive beliefs, and the content of specific negative thoughts may not need to be directly addressed.
“This finding suggests that the frequency of negative thoughts reduced as a side effect of targeting metacognitive beliefs and, as such, the content of specific negative thoughts may not need to be directly addressed.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll analyses followed an intent-to-treat approach.
“All analyses were intent-to-treat (ITT) and were conducted using the statistical software R version 3.0.1 (R Core Team, 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites R Core Team, 2013
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataInternal consistency was high for all symptom and quality-of-life measures in this sample (alpha .85 to .94).
“Cronbach's alphas for all symptom and quality of life measures were high (αs=.85-.94).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe MCQ positive subscale assesses favorable beliefs about worry, while the negative subscale assesses beliefs that worry is uncontrollable and dangerous.
“The MCQ-POS is a measure of positive beliefs about worry, while the MCQ-NEG measures negative beliefs about the uncontrollability and dangerousness of worry.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wells & Cartwright-Hatton, 2004 source
May combine two claims.
Interpretationown dataGroup metacognitive therapy was acceptable to patients, as indicated by most attending five or six of the six sessions.
“Most patients attended 5 or 6 sessions of the six-session program, suggesting that they found MCT an acceptable way of targeting their RNT.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe RTQ-10 is a transdiagnostic repetitive negative thinking measure with a strong unidimensional structure, it separates clinical from non-clinical groups, and it correlates at r = .95 with the full 27-item version.
“The RTQ-10 (Mahoney, McEvoy, & Moulds, 2012;McEvoy, Mahoney, & Moulds, 2010) is a transdiagnostic measure of RNT that has a robust unidimensional structure, distinguishes between clinical and non-clinical populations, and correlates very highly (r = .95)with the full 27-item scale (McEvoy et al., 2010;McEvoy, Thibodeau, & Asmundson, 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenEvery senior therapist had substantial group facilitation experience, and most had worked on earlier effectiveness studies.
“All senior therapists had extensive experience at facilitating group interventions, with most participating in previous treatment effectiveness studies.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataMetacognitive therapy has a large impact on diagnosis-specific measures of worry and rumination and on transdiagnostic measures of repetitive negative thinking.
“This finding suggests that MCT has a large impact on diagnosis-specific (i.e., worry and rumination) and transdiagnostic measures of RNT.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenSessions were not recorded to evaluate protocol adherence and therapist competence, and diagnoses were not confirmed by a second assessor.
“Secondly, sessions were not recorded to evaluate protocol adherence and therapist competence, and diagnoses were not confirm by a second assessor.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA treatment manual containing detailed therapist notes, worksheets, and client handouts helped support fidelity.
“Treatment fidelity was supported by the use of a treatment manual that included detailed therapist notes, worksheets, and client handouts.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLadouceur et al. (2000) evaluated a 16-week Intolerance of Uncertainty Therapy protocol in a relatively small sample of 26 people with primary generalized anxiety disorder based on the Intolerance of Uncertainty Model.
“Ladouceur et al. (2000) evaluated a 16-week Intolerance of Uncertainty Therapy (IUT) protocol in a relatively small sample (N = 26) with primary GAD based on the Intolerance of Uncertainty Model.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ladouceur et al. (2000) source
May combine two claims.
Interpretationown dataBrief group metacognitive therapy appears acceptable and highly effective for people whose GAD is either primary or non-primary.
“Brief metacognitive therapy is an acceptable and powerful treatment for patients with primary or non-primary GAD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDugas et al. (2003) group treatment averaged 5.6 therapy hours and 11.2 therapist hours per patient.
“Using similar calculations,Dugas et al.'s (2003) groups included used an average of 5.6 therapy hours/patient and 11.2 therapist hours/patient.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dugas et al. (2003) source
May combine two claims.
PremisecitationVan der Heiden et al. (2012) delivered group treatment to 10-14 patients in 14 sessions of 90 minutes, which averaged 1.91 therapy hours and 3.82 therapist hours per patient.
“Van der Heiden et al.'s (2012) groups included 10-14 patients over 14, 90-minute sessions, resulting in an average of 1.91 therapy hours/patient and 3.82 therapist hours/patient”
Quote in the paperSubstantial claim0 of 1 sources checked- cites van der Heiden et al. (2012) source
May combine two claims.
InterpretationreasoningTransdiagnostic group treatments may be an effective, efficient, and pragmatic way of offering treatment to a broader array of individuals.
“Transdiagnostic group treatments may be an effective, efficient, and pragmatic way of offering treatment to a broader array of individuals.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationOne hundred imputations were produced with a robust model-based imputation algorithm.
“One hundred imputations were generated using the robust model based imputation algorithm (Templ, Kowarik, & Filzmoser, 2011) implemented in the R package VIM (Templ, Alfons, Kowarik, & Prantner, 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Templ, Kowarik, & Filzmoser, 2011 source
- cites Templ, Alfons, Kowarik, & Prantner, 2013
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationLadouceur et al. found a slightly larger effect size than this study at follow-up, and outcomes may be comparable 16 weeks after starting the brief metacognitive therapy protocol.
“These researchers found a slightly larger effect size than ours at follow-up and, again, outcomes may be comparable 16-weeks after commencement of our brief MCT protocol.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ladouceur et al. (2000) source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataInternal consistency was high for all Cognitions Checklist and Metacognitions Questionnaire subscales in this sample (alpha .73 to .96).
“In this study Cronbach's alphas were high for all CCL and MCQ subscales (αs=.73-.96).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe study lacked a control group and independent checks of protocol adherence.
“No control group or independent assessment of protocol adherence.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationMultiple imputation was used to handle missing data.
“Missing data were handled using multiple imputation (National Research Council Panel on Handling Missing Data in Clinical Trials, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites National Research Council Panel on Handling Missing Data in Clinical Trials, 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenThe brevity of the metacognitive therapy program makes it easier for therapists to schedule and may help minimize attrition without compromising the magnitude of change compared with longer programs.
“The brevity of the MCT program evaluated in this study makes it easier for therapists to schedule, and may help to minimize attrition without compromising the magnitude of change, compared to longer programs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe Ruminative Responses Scale measures the tendency to ruminate while feeling sad, blue, or depressed.
“while the RRS assesses the tendency to ruminate when feeling sad, blue or depressed.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataTransdiagnostic metacognitive therapy appears to be an acceptable, effective, efficient, and practical intervention for targeting repetitive negative thinking in emotional disorders.
“Transdiagnostic MCT appears to be an acceptable, effective, efficient, and practical intervention for targeting RNT in emotional disorders.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThis study's treatment required therapist hours per patient similar to van der Heiden et al.'s (2012) group treatment but substantially fewer than the other comparison treatments.
“Therefore, the treatment in this study required similar therapist hours per patient tovan der Heiden et al.'s (2012) group treatment but substantially less than the other comparison treatments.”
Quote in the paperNot a substantial claim- Rests on an assumption: Therapist hours per patient is a meaningful and comparable measure of treatment intensity across studies.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenSenior therapists held master's and/or doctoral degrees in clinical psychology and took part in weekly peer supervision.
“Senior therapists had completed masters and/or doctoral degrees in clinical psychology and received weekly peer supervision.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe Penn State Worry Questionnaire is a 16-item trait measure of pathological worry commonly used as a primary outcome in GAD treatment research.
“The PSWQ (Meyers, Miller, Metzger, & Borkovec, 1990) is a 16-item trait measure of pathological worry often used as the primary symptom measure in GAD treatment studies”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Meyers, Miller, Metzger, & Borkovec, 1990 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataDropout reasons were session clash (n=3), child's medical appointment (n=1), moved away (n=1), and unexplained dropout (n=4).
“Figure session (n=3) Clashed with child's medical appointment (n=1)Moved away (n=1) Unexplained dropout (n=4)”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Before this study, group metacognitive therapy had not been tested in a sample containing both primary and non-primary GAD.
“No previous study has evaluated group-based MCT in a sample with primary or non-primary GAD.”
The paper relies on this without support.
In many settings, organizing separate groups by primary diagnosis may not be practical.
“it may be impractical in many settings to run diagnosis-specific groups based on primary disorders”
The paper relies on this without support.
A shorter protocol was expected to lower dropout and the amount of clinician time each patient required.
“The shorter duration was expected to minimize attrition rates and clinician time per patient”
The paper relies on this without support.
This is the first treatment study to compare the sensitivity to change of the RTQ as a transdiagnostic measure of repetitive negative thinking with diagnosis-specific measures.
“Although the psychometric properties of the RTQ are now well established (Mahoney et al., 2012;McEvoy et al., 2010;McEvoy et al., 2014), this is the first treatment study to compare the sensitivity to change of the RTQ as a measure of transdiagnostic RNT to diagnosis-specific measures.”
The paper relies on this without support.
This study is the first to evaluate the effectiveness of group metacognitive therapy for a sample with primary or non-primary generalized anxiety disorder in a community mental health clinic.
“This study is the first to evaluate the effectiveness of group MCT for a sample with primary or non-primary GAD in a community mental health clinic.”
The paper relies on this without support.
Many community clinics may not receive enough referrals to run groups based on primary disorders.
“which is important because many community clinics may not receive enough referrals to run groups based on primary disorders.”
The paper relies on this without support.
Effect sizes from different studies can be validly compared using benchmarking.
“Benchmarking comparisons found that the brief, 6-week MCT group program evaluated in this study was associated with substantially larger changes in worry than van der Heiden et al.'s (2013) group treatment”
The paper relies on this without support.
Therapist hours per patient is a meaningful and comparable measure of treatment intensity across studies.
“Therefore, the treatment in this study required similar therapist hours per patient tovan der Heiden et al.'s (2012) group treatment but substantially less than the other comparison treatments.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Medication-use median changes between sections
MinorThe participant description gives a median medication-use duration of one year, while the discussion gives two years for the same duration.
“About two-thirds of patients were taking psychiatric medication (N = 35, 67%) for an extended period of time (median 1 year; interquartile range 6 months to 4 years) without responding adequately.”
“the long duration of medication use (median = 2 years)”
Follow-up reliable-improvement rates disagree
MinorThe first account says reliable improvement was 86% at both post-treatment and follow-up. The later account gives 90% at follow-up, although reliable improvement is defined by a seven-point change and does not depend on which recovery cutoff is used.
“86% had reliably improved, CI [77%, 96%], p < .001,and 74% had recovered, CI [62%, 86%], p <.001.The percentages were the same at follow up.”
“When a lower PSWQ cutoff of 53 was used, which has been applied in some recent studies, 85% and 90% achieved reliable improvement at post-treatment and follow-up, respectively”
Group-treatment comparison is assigned to the individual-treatment study
MinorThe comparison describes the 2012 study as having groups of 10-14 patients. Elsewhere, the paper assigns groups of that size to the 2013 study and identifies the 2012 treatment as individual MCT.
“Van der Heiden et al.'s (2012) groups included 10-14 patients over 14, 90-minute sessions”
“It is notable that van der Heiden et al.'s (2013) groups were relatively large (10-14 patients/group)”
Discussion describes positive affect as decreasing
MinorThe discussion groups positive affect among the reductions it says were supported, but the reported positive-affect mean increased from 25.47 to 29.24 after treatment.
“It was hypothesized that group MCT would be acceptable to patients, and would be associated with significant reductions in positive and negative metacognitive beliefs, RNT, anxious and depressive thoughts, positive and negative affect, and improved quality of life.It was also expected that these outcomes would compare favorably to previous trials of MCT for primary GAD.These hypotheses were supported.”
“Positive Affect (PANAS-POS) Pre 25.47 7.25 Post 29.24 6.57”
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,706 · see citing works
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433 · see citing works
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · see citing works
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052 · see citing works
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327 · see citing works
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · see citing works
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,882 · see citing works
Development and validation of the Penn State Worry Questionnaire
Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990) · Behaviour Research and Therapy · doi:10.1016/0005-7967(90)90135-6 · Cited by 5,099 · see citing works
Responses to depression and their effects on the duration of depressive episodes
Nolen-Hoeksema, S. (1991) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.100.4.569 · Cited by 4,529 · see citing works
Rumination reconsidered: a psychometric analysis.
Treynor, W., Gonzalez, R., & Nolen-Hoeksema, S. (2003) · Cognitive Therapy and Research · doi:10.1023/a:1023910315561 · Cited by 3,808 · see citing works
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513 · see citing works
(2011) · Cited by 2,025 · see citing works
Flexible Imputation of Missing Data
van Buuren, S. (2012) · doi:10.1201/b11826 · Cited by 2,022 · see citing works
(1993) · PubMed · Cited by 1,900 · see citing works
The prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884 · see citing works
Brown, T. A., Campbell, L. A., Lehman, C. L., Grisham, J. R., & Mancill, R. B. (2001) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.110.4.585 · Cited by 1,562 · see citing works
Preliminary exploration of worry: Some characteristics and processes
Borkovec, T. D., Robinson, E., Pruzinsky, T., & DePree, J. A. (1983) · Behaviour Research and Therapy · doi:10.1016/0005-7967(83)90121-3 · Cited by 1,468 · see citing works
A short form of the metacognitions questionnaire: properties of the MCQ-30
Wells, A., & Cartwright-Hatton, S. (2004) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(03)00147-5 · Cited by 1,396 · see citing works
Modelling cognition in emotional disorder: the S-REF model
Wells, A., & Matthews, G. (1996) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(96)00050-2 · Cited by 1,067 · see citing works
(2008) · Research Explorer (The University of Manchester) · Cited by 988 · see citing works
(2004) · Cited by 964 · see citing works
Nolen-Hoeksema, S., & Watkins, E. R. (2011) · Perspectives on Psychological Science · doi:10.1177/1745691611419672 · Cited by 863 · see citing works
Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: A Randomized Controlled Trial
Farchione, T. J., Fairholme, C. P., Ellard, K. K., Boisseau, C. L., Thompson-Hollands, J., Carl, J. R., Gallagher, M. W., & Barlow, D. H. (2012) · Behavior Therapy · doi:10.1016/j.beth.2012.01.001 · Cited by 746 · see citing works
Differentiating anxiety and depression: A test of the cognitive content-specificity hypothesis.
Beck, A. T., Brown, G. P., Steer, R. A., Eidelson, J. I., & al, E. (1987) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.96.3.179 · Cited by 707 · see citing works
Differentiating anxiety and depression: A test of the cognitive content-specificity hypothesis.
Beck, A. T., Brown, G. P., Steer, R. A., et al. (1987) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.96.3.179 · Cited by 529 · see citing works
Roemer, L., Orsillo, S. M., & Salters-Pedneault, K. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0012720 · Cited by 502 · see citing works
Stewart, R. E., & Chambless, D. L. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0016032 · Cited by 483 · see citing works
Ladouceur, R., Dugas, M. J., Freeston, M. H., Léger, E., Gagnon, F., & Thibodeau, N. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.6.957 · Cited by 446 · see citing works
The Prevention and Treatment of Missing Data in Clinical Trials
National Research Council (2010) · National Academies Press eBooks · doi:10.17226/12955 · Cited by 439 · see citing works
Jacobson, N. S., & Truax, P. (1992) · Methodological issues & strategies in clinical research. · doi:10.1037/10109-042 · Cited by 384 · see citing works
The effects of psychological therapies under clinically representative conditions: a meta-analysis
Shadish, W. R., Navarro, A. M., Matt, G. E., & Phillips, G. (2000) · Psychological Bulletin · doi:10.1037/0033-2909.126.4.512 · Cited by 381 · see citing works
Are worry, rumination, and post-event processing one and the same?
McEvoy, P. M., Mahoney, A. E. J., & Moulds, M. L. (2010) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.03.008 · Cited by 360 · see citing works
Self-citationDugas, M. J., Ladouceur, R., Léger, E., Freeston, M. H., Langolis, F., Provencher, M. D., & Boisvert, J.-M. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.821 · Cited by 331 · see citing works
An Open Trial of an Acceptance-Based Behavior Therapy for Generalized Anxiety Disorder
Roemer, L., & Orsillo, S. M. (2007) · Behavior Therapy · doi:10.1016/j.beth.2006.04.004 · Cited by 282 · see citing works
van der Heiden, C., Muris, P., & van der Molen, H. T. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.12.005 · Cited by 265 · see citing works
Metacognitive therapy for generalized anxiety disorder: An open trial
Wells, A., & King, P. (2006) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2005.07.002 · Cited by 254 · see citing works
McEvoy, P. M., Grove, R., & Slade, T. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.624083 · Cited by 229 · see citing works
Self-citationThe dissemination of empirically supported treatments: a view to the future
Barlow, D. H., Levitt, J. T., & Bufka, L. F. (1999) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(99)00054-6 · Cited by 227 · see citing works
Judd, L. L., Kessler, R. C., PauIus, M. P., Zeller, P. V., Wittchen, H. ‐., & Kunovac, J. L. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb05960.x · Cited by 222 · see citing works
Dugas, M. J., Brillon, P., Savard, P., Turcotte, J., Gaudet, A., Ladouceur, R., Leblanc, R., & Gervais, N. J. (2010) · Behavior Therapy · doi:10.1016/j.beth.2008.12.004 · Cited by 216 · see citing works
Leichsenring, F., Salzer, S., Jaeger, U., Kächele, H., Kreische, R., Leweke, F., Rüger, U., Winkelbach, C., & Leibing, E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030441 · Cited by 207 · see citing works
Advances in metacognitive therapy
Wells, A. (2013) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2013.6.2.186 · Cited by 204 · see citing works
Wells, A., Welford, M., King, P., Papageorgiou, C., Wisely, J., & Mendel, E. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.11.013 · Cited by 195 · see citing works
Newby, J. M., Mackenzie, A., Williams, A. D., McIntyre, K., Watts, S., Wong, N., & Andrews, G. (2013) · Psychological Medicine · doi:10.1017/s0033291713000111 · Cited by 181 · see citing works
Newman, M. G., Castonguay, L. G., Borkovec, T. D., Fisher, A. J., Boswell, J. F., Szkodny, L. E., & Nordberg, S. S. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0022489 · Cited by 174 · see citing works
Iterative stepwise regression imputation using standard and robust methods
Templ, M., Kowarik, A., & Filzmoser, P. (2011) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2011.04.012 · Cited by 169 · see citing works
Hayes-Skelton, S. A., Roemer, L., & Orsillo, S. M. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0032871 · Cited by 153 · see citing works
Metacognitive therapy in treatment-resistant depression: A platform trial
Wells, A., Fisher, P., Myers, S., Wheatley, J., Patel, T., & Brewin, C. R. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2012.02.004 · Cited by 145 · see citing works
A meta-analysis of cognitive therapy for worry in generalized anxiety disorder
Hanrahan, F., Field, A. P., Jones, F. W., & Davey, G. C. L. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.10.008 · Cited by 135 · see citing works
An open trial of group metacognitive therapy for obsessive-compulsive disorder
Rees, C. S., & van Koesveld, K. E. (2008) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2007.11.004 · Cited by 123 · see citing works
Gosselin, P., Ladouceur, R., Morin, C. M., Dugas, M. J., & Baillargeon, L. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.5.908 · Cited by 122 · see citing works
Psychometric properties of the Repetitive Thinking Questionnaire in a clinical sample
Mahoney, A. E. J., McEvoy, P. M., & Moulds, M. L. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.12.003 · Cited by 109 · see citing works
Self-citationTrait Repetitive Negative Thinking: A Brief Transdiagnostic Assessment
McEvoy, P. M., Thibodeau, M. A., & Asmundson, G. J. G. (2014) · Journal of Experimental Psychopathology · doi:10.5127/jep.037813 · Cited by 104 · see citing works
Self-citationMcEvoy, P. M., & Brans, S. (2013) · Cognitive Therapy and Research · doi:10.1007/s10608-012-9448-5 · Cited by 87 · see citing works
Self-citationMcEvoy, P. M., Mahoney, A., Perini, S. J., & Kingsep, P. (2009) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2009.01.011 · Cited by 85 · see citing works
Self-citationThe gap between science and practice: how therapists make their clinical decisions
Gyani, A., Shafran, R., Myles, P., & Rose, S. (2014) · Behavior Therapy · doi:10.1016/j.beth.2013.10.004 · Cited by 73 · see citing works
Combined medication and cognitive therapy for generalized anxiety disorder
Crits-Christoph, P. F., Newman, M. G., Rickels, K., Gallop, R., Gibbons, M. B. C., Hamilton, J. L., Ring‐Kurtz, S., & Pastva, A. M. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.07.007 · Cited by 67 · see citing works
VIM: Visualization and Imputation of Missing Values
Templ, M., Kowarik, A., Alfons, A., Gussenbauer, J., Niederhametner, N., Vattheuer, E., de Cillia, G., & Rannetbauer, W. (2012) · doi:10.32614/cran.package.vim · Cited by 61 · see citing works
Papageorgiou, C., & Adrian Wells, A. (2014) · Cognitive Therapy and Research · doi:10.1007/s10608-014-9632-x · Cited by 52 · see citing works
An open trial of group metacognitive therapy for depression in Norway
Dammen, T., Papageorgiou, C., & Adrian Wells, A. (2014) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2014.936502 · Cited by 49 · see citing works
Normative data for the Dutch version of the Penn State Worry Questionnaire
van der Heiden, C., Muris, P., Bos, A. E. R., van der Molen, H., & Oostra, M. (2009) · Netherlands Journal of Psychology · doi:10.1007/bf03080129 · Cited by 37 · see citing works
The effectiveness of group metacognitive therapy for generalised anxiety disorder: a pilot study
van der Heiden, C., Melchior, K., & de Stigter, E. (2013) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-013-9235-y · Cited by 26 · see citing works
Leichsenring, F., Salzer, S., Jaeger, U., Kächele, H. U., Kreische, R., Leweke, F., Rüger, U., Winkelbach, C., & Leibing, E. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.1.foc66 · Cited by 9 · see citing works
An Exploration of Some Behavioral Techniques For Toxicity Testing
Teichner, W. H. (1967) · The Journal of Psychology · doi:10.1080/00223980.1967.10543823 · Cited by 6 · see citing works
Adrian Wells, A. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt06 · Cited by 6 · see citing works
Flagged first, then by citations
3 of the 70 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Kraiss, J. T., ten Klooster, P. M., Moskowitz, J. T., & Bohlmeijer, E. T. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2020.152189 · Cited by 252 · see citing works
Toward a unified treatment for emotional disorders: Update on the science and practice
Norton, P. J., & Paulus, D. J. (2016) · Behavior Therapy · doi:10.1016/j.beth.2015.07.002 · Cited by 180 · see citing works
McEvoy, P. M., & Erceg-Hurn, D. M. (2016) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2016.02.002 · Cited by 155 · see citing works
Self-citationCapobianco, L., Reeves, D., Morrison, A. P., & Adrian Wells, A. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.045 · Cited by 78 · see citing works
“Additionally, McEvoy et al. (2015) investigated group MCT in adults suffering from primary or secondary GAD, and found large effect sizes from pre to post treatment on the BDI-II, d = 0.86, and a medium effect size from pre to post treatment on measure of anxiety, d = 0.58.”
InfluentialJohnson, S. U., Hoffart, A., Nordahl, H. M., & Wampold, B. E. (2017) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2017.06.004 · Cited by 67 · see citing works
McEvoy, P. M. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1014-3 · Cited by 55 · see citing works
Self-citationRepetitive negative thinking as a transdiagnostic cognitive process
Moulds, M. L., & McEvoy, P. M. (2025) · Nature Reviews Psychology · doi:10.1038/s44159-024-00399-6 · Cited by 55 · see citing works
“…metacognitive therapy for RNT in people with generalized anxiety disorder and non-primary generalized anxiety disorder (disorder present but less severe than, and/or functionally secondary to, another disorder) comprising group sessions of 2 h per week for 6 weeks plus a 1-month follow-up 115,116 .”
Self-citationMcEvoy, P. M., Erceg‐Hurn, D. M., Anderson, R., Campbell, B. N. C., & Nathan, P. R. (2015) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2015.07.003 · Cited by 38 · see citing works
Self-citationMcEvoy, P. M., Graville, R., Hayes, S., Kane, R. T., & Foster, J. K. (2017) · Behavior Therapy · doi:10.1016/j.beth.2017.04.001 · Cited by 34 · see citing works
Self-citationMansell, W., & McEvoy, P. M. (2017) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2016.06.008 · Cited by 30 · see citing works
Self-citationEgan, S. J., Kane, R. T., Winton, K., Eliot, C., & McEvoy, P. M. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.06.006 · Cited by 29 · see citing works
“Exploration of these processes in perinatal depression may hold promise given treatments for perfectionism and repetitive negative thinking have been found to reduce symptoms of a wide range of psychological disorders (Egan, Wade, & Shafran, 2011; McEvoy et al., 2015).”
BackgroundSelf-citationGroup metacognitive therapy for adolescents with anxiety and depressive disorders: A pilot study
Thorslund, J., McEvoy, P. M., & Anderson, R. (2020) · Journal of Clinical Psychology · doi:10.1002/jclp.22914 · Cited by 29 · see citing works
Self-citationCognitive-behavioral therapy (CBT) for generalized anxiety disorder (GAD)
Newman, M. G., Zainal, N. H., & Hoyer, J. (2020) · Generalized Anxiety Disorder and Worrying · doi:10.1002/9781119189909.ch10 · Cited by 25 · see citing works
Efficacy of an acceptance-based group behavioral therapy for generalized anxiety disorder.
Almeida Sampaio, T. P., Jorge, R. C., Martins, D. S., Gandarela, L. M., Hayes‐Skelton, S., Bernik, M. A., & Lotufo‐Neto, F. (2020) · Depression and Anxiety · doi:10.1002/da.23021 · Cited by 23 · see citing works
“Similarly, McEvoy et al. (2015) showed a large effect size for PSWQ at posttreatment (d = 1.34) and even more improvement at follow‐up (d = 1.66) in an effectiveness trial of metacognitive therapy for GAD.”
BackgroundMethodInfluentialWells, A., Reeves, D., Heal, C., Fisher, P., Davies, L., Heagerty, A., Doherty, P., & Capobianco, L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00582 · Cited by 18 · see citing works
Callesen, P., Capobianco, L., Heal, C., Juul, C., Nielsen, S. F., & Adrian Wells, A. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01341 · Cited by 15 · see citing works
Nooripour, R., Nasershariati, M. A., Amirinia, M., Ilanloo, H., Habibi, A., & Chogani, M. (2023) · Practice in Clinical Psychology · doi:10.32598/jpcp.11.2.288.8 · Cited by 15 · see citing works
Egan, S. J., Greene, D., Callaghan, T., Raghav, S., Funk, J., Badenbach, T., Talam, S., Kemp, G., McEvoy, P. M., Ehring, T. W., et al. (2024) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2024.2369936 · Cited by 23 · see citing works
“Interventions for RNT decrease psychological distress and improve quality of life with large effect sizes in adults (e.g. McEvoy et al., 2015).”
Self-citationA qualitative approach – delineates changes on pubertal body image after menarche
Riboli, G., Borlimi, R., & Caselli, G. (2022) · International Journal of Adolescence and Youth · doi:10.1080/02673843.2022.2032219 · Cited by 17 · see citing works
“…it will be important to create programs that include exercises with easy-to-apply metacognitive techniques that adolescents can adopt when faced with repetitive concerns that, according to the literature, only feed their negative emotions and discomfort (McEvoy, 2019; McEvoy et al., 2015).”
BackgroundMalouf, P., Quinlan, E., & Mohi, S. R. (2023) · Clinical Psychologist · doi:10.1080/13284207.2022.2163159 · Cited by 11 · see citing works
Rogiers, R., Baeken, C., den Abbeele, D. V., Watkins, E. R., Remue, J., Colman, R., Raedt, R. D., & Lemmens, G. M. D. (2021) · Cognitive Therapy and Research · doi:10.1007/s10608-021-10240-6 · Cited by 11 · see citing works
Havnen, A., Anyan, F., & Nordahl, H. (2024) · Scandinavian Journal of Psychology · doi:10.1111/sjop.13015 · Cited by 9 · see citing works
Hasani, M., Zenoozian, S., Ahmadi, R., Khakpoor, S., Saberi, S., Pirzeh, R., & Saed, O. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07065-y · Cited by 8 · see citing works
Jolly, A. T. W., Garratt‐Reed, D., & McEvoy, P. M. (2021) · Anxiety Stress & Coping · doi:10.1080/10615806.2021.1994142 · Cited by 7 · see citing works
“Furthermore, if RNT is identified as a mediating variable, it may open doors to empirical inquiry regarding the effectiveness of targeting RNT in intervention strategies (such as group metacognitive therapy; McEvoy et al., 2015) to mitigate the effects of cognitive TA.”
BackgroundSelf-citationSeow, T. X. F., Jelinek, L., Moritz, S., & Hauser, T. U. (2025) · Nature Reviews Psychology · doi:10.1038/s44159-025-00503-4 · Cited by 10 · see citing works
Chai, K. E. K., Graham-Schmidt, K., Lee, C., Rock, D. J., Coleman, M., Betts, K. S., Robinson, S., & McEvoy, P. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-71557-2 · Cited by 7 · see citing works
“The K10 has high internal reliability (Cronbach’s alpha = 0.93) 21 , distinguishes people with and without anxiety disorders 22 , and has been shown to be highly sensitive to change during psychotherapy 23 .”
BackgroundInfluentialSelf-citationPatient motivation in group metacognitive therapy for generalized anxiety disorder
Lassen, E. R., Touil, M., Svendsen, T. L., Haseth, S., & Solem, S. (2021) · Psychotherapy Research · doi:10.1080/10503307.2021.2001068 · Cited by 6 · see citing works
“However, three open trials of g-MCT for GAD have revealed promising results (Haseth et al., 2019; McEvoy et al., 2015; van der Heiden et al., 2013).”
BackgroundCognitive‐Behavioral Models of Generalized Anxiety Disorder (GAD)
Koerner, N., McEvoy, P. M., & Tallon, K. (2020) · Wiley eBooks · doi:10.1002/9781119189909.ch7 · Cited by 9 · see citing works
Self-citationUpton, E., Venkatesha, V., Joubert, A., Mahoney, A. E. J., Moulds, M. L., Werner-Seidler, A., & Newby, J. M. (2025) · Cognitive Therapy and Research · doi:10.1007/s10608-025-10593-2 · Cited by 5 · see citing works
“Some studies of one type of RNT-focused intervention, metacog - nitive therapy for GAD, found that reductions in negative beliefs about worry mediated reduction in worry over treat - ment (McEvoy et al., 2015 ; Wahlund et al., 2022).”
Generalized anxiety symptoms and life satisfaction
Peixoto, M. M., Ribeiro, V., & Cunha, O. S. (2023) · Psychologica · doi:10.14195/1647-8606_66_5 · Cited by 6 · see citing works
“From cognitive-behavioral psychotherapy (McEvoy et al., 2015) to action and commitment therapy (Ruiz et al., 2019) or metacognitive therapy (Newby et al., 2014), empirical evidence suggests that psychotherapeutic interventions that address RNT as a transdiagnostic process involved in the emergence…”
BackgroundResultInfluentialRogiers, R., Parys, H. V., Baeken, C., den Abbeele, D. V., Remue, J., Raedt, R. D., & Lemmens, G. M. D. (2021) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.12378 · Cited by 4 · see citing works
White, J. A., Rapee, R. M., Stapinski, L. A., & Abbott, M. J. (2024) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-024-10142-3 · Cited by 3 · see citing works
“Alter-natively, it has been suggested that negative beliefs may be more salient prior to treatment, due to the distress and interference associated with clinical levels of GAD (McEvoy et al., 2015a).”
InfluentialMukai, H., Takagishi, Y., & Sugiura, Y. (2018) · The Japanese Journal of Personality · doi:10.2132/personality.26.3.10 · Cited by 3 · see citing works
Online Group Metacognitive Therapy for Repetitive Negative Thinking: A Pilot Study
Mazza, S., Kieran, M., Tonta, K. E., Erceg‐Hurn, D. M., Swan, A., Campbell, B. N. C., & McEvoy, P. M. (2025) · Behavior Therapy · doi:10.1016/j.beth.2025.04.004 · Cited by 2 · see citing works
Self-citationGodini, A. A., Rasouli, M., & Mohsenzadeh, F. (2019) · International Clinical Neuroscience Journal · doi:10.15171/icnj.2019.19 · Cited by 2 · see citing works
The Psychological Treatment of Generalized Anxiety Disorder
McCabe‐Bennett, H., Fracalanza, K., & Antony, M. M. (2017) · Wiley eBooks · doi:10.1002/9781119462996.ch5 · Cited by 2 · see citing works
The role of acceptance and cognitive reappraisal in valued living: a structural equation model
Tehranchi, A., Davari, F., & Mokhtari, F. (2024) · Current Psychology · doi:10.1007/s12144-024-06464-w · Cited by 1 · see citing works
“This questionnaire demonstrated good internal consistency and construct validity in both clinical and non-clinical samples (McEvoy et al., 2010, 2015).”
Mukai, H., & Sugiura, Y. (2022) · The Japanese Journal of Personality · doi:10.2132/personality.31.3.1 · Cited by 1 · see citing works
Rogiers, R., Baeken, C., Watkins, E., van den Abbeele, D., Remue, J., de Raedt, R., & Lemmens, G. (2022) · International journal of group psychotherapy · doi:10.1080/00207284.2022.2066535 · Cited by 1 · see citing works
“We also provide practical guidelines for clinicians treating patients with RNT. 257 R epetitive negative thinking (RNT), including worry and rumination, has received increasing attention as a transdiagnostic factor of vulnerability to the development and course of generalized anxiety disorder (GAD; Borkovec & Inz, 199…”
MethodResultInfluentialMetakognitiv gruppeterapi for pasienter med generalisert angstlidelse : en pilotstudie
Larsen, T. K. (2015) · BIBSYS Brage (BIBSYS (Norway))
Fear of emotion: Association with anxiety and depressive disorders and response to treatment
Campbell, B. N. C. (2017) · Murdoch University Research Portal
Self-citationMetacognition, stress & recovery
Capobianco, L. (2017) · Research Explorer (The University of Manchester)
Sampaio, T. P. D. A. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2020.tde-28052020-192438
Transdiagnostic Approaches to Mental Disorders
McEvoy, P. M. (2021) · Comprehensive Clinical Psychology · doi:10.1016/b978-0-12-818697-8.00097-2
Self-citationCognitieve therapie bij gegeneraliseerde angststoornis
van der Heiden, C. (2019) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2021-9_5
Javidnia, N., Mehrinejad, S. A., & Moazedian, A. (2022) · doi:10.61838/kman.aftj.3.1.25
الحميد, ه. ج. ع. (2023) · Journal of Educational Sciences - Qena Faculty of Education · doi:10.21608/maeq.2023.336409
Arda, D. U., & Yılmaz, A. E. (2025) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1621073 · Cited by 1 · see citing works
“…delivered in an individual therapy format in six studies (Wells and King 2006, Wells et al. 2010 In most studies, MCT treatment guidelines for adults by Wells (1997, 2009) were followed, while one study (McEvoy et al. 2015) employed the group MCT manual developed by Anderson and Campbell (2011).”
InfluentialJørgensen, H. F., Helvig, E. K., Schei, H., Stormyren, S. D., Steffensen, E., & Johnson, S. U. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1766026 · Cited by 1 · see citing works
“…across various adult clinical populations, reporting large effect sizes for symptoms of anxiety, depression, and dysfunctional metacognition (8, 14, 23 – 25); there remains a notable de fi cit of empirical research focused speci fi cally on university students Hence, there is still considerable…”
Gökdağ, C., Meral, Y., & Dumlu-Gündoğan, S. (2026) · International Journal of Cognitive Behavioral Therapy · doi:10.1007/s41811-026-00282-7
“…psychotherapeutic approaches, including metacognitive therapy, mindfulness-based therapy, acceptance and commitment therapy, and compassion-focused therapy, are effective in reducing RNT levels (e.g., Mao et al., 2023; McEvoy et al., 2015; Ruiz et al., 2020a, b; Torres Lancheros et al., 2023).”
Ban, D. P. (2026) · International journal of evidence based coaching and mentoring · doi:10.1177/17418305261461880
“Both techniques have been demonstrated to be effective in reducing negative thinking (McEvoy et al., 2015).”
Maksic, E., Klæth, J. R., Nordahl, H. M., & Hjemdal, O. (2026) · International Journal of Cognitive Behavioral Therapy · doi:10.1007/s41811-026-00290-7
- Authors
- McEvoy, P. M., Erceg-Hurn, D. M., Anderson, R. A., Campbell, B. N. C., Swan, A., Saulsman, L. M., Summers, M., & Nathan, P. R.
- Affiliations
- Curtin University (AU)
- Centre for Clinical Interventions (AU)
- The University of Western Australia (AU)
- Corresponding author
- McEvoy, Peter M.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 175
- Pages
- 124-132
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2041123175
- Cited by
- 54
- References
- 70
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 5 · 2018: 2 · 2017: 7 · 2016: 2 · 2015: 3
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- eSpace (Curtin University) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Assessments
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- generalized anxiety disorder, repetitive negative thinking, metacognitive therapy, group therapy, metacognitive beliefs, treatment acceptability, community mental health services, quality of life, negative affect
- MeSH terms
- Adult, Aged, Anxiety, Anxiety Disorders, Emotions, Female, Humans, Male, Middle Aged, Negativism, Patient Acceptance of Health Care, Psychotherapy, Group, Stress Disorders, Post-Traumatic, Thinking, Cognitive Behavioral Therapy, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-01.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-01.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review